NCT06740591Active, not recruiting
HD-tDCS for Pain Reduction in Post-Stroke Pain: a Randomized Crossover Trial
Evaluation of the Efficacy and Safety of High-Definition Transcranial Direct Current Stimulation for Pain Reduction in Post-Stroke Pain Patients: Investigator-Initiated, Single-Center, Randomized, Crossover, Single-Blind Clinical Trial
Source: ClinicalTrials.gov · Last updated 18 Dec 2024
Brief summary (registry, in English)
This study aims to assess the effectiveness of multichannel transcranial direct current stimulation (tDCS) in alleviating pain and to evaluate its safety in patients with central post-stroke pain (CPSP)
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 13 Dec 2024
- Start date
- 24 Nov 2023
- Primary completion date
- 24 Apr 2024
- Lead sponsor
- Pusan National University Yangsan Hospital
- Diseases
- Stroke
- NCT number
- NCT06740591
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 24 Nov 2023 to the primary completion date, 24 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of fractures or orthopedic surgeries on the affected side.
- Presence of significant pre-existing neurogenic disorders.
- Co-existing severe psychiatric disorders such as major depressive disorder, schizophrenia, bipolar disorder, or dementia.
- Complex regional pain syndrome (CRPS) diagnosed based on Budapest criteria.
- Exclusion criteria for transcranial magnetic stimulation (e.g., pregnancy, cancer, patients with abnormal responses to stimulation, presence of intracranial metal implants, hypersensitivity to pain, history of seizures, or injuries/skin conditions at electrode attachment sites).
Other
- Other causes of pain in the affected area, such as peripheral nerve damage.
- Deemed unsuitable for participation in the study by the principal investigator.
Who the study is looking for
- Adults aged between 19 and 90 years.
- Diagnosed with first-ever stroke based on clinical observation and neuroimaging by a physician.
- Stroke lesion located in the cortex or subcortex \[basal ganglia (BG) or thalamus\].
- Fulfillment of mandatory criteria for pain (pain in the body part corresponding to central nervous system lesions, onset of pain immediately after stroke, confirmation that the pain corresponds to the lesion site, exclusion of other causes of pain such as peripheral neuropathic pain).
- Cognitive ability sufficient to understand and follow the instructions of the researcher.
- Voluntary consent to participate in the clinical trial and signed informed consent.
Age in the registry: 19 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pusan National University Yangsan Hospital Coordinator of this site? Confirm its status | Gyeongsang | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.